Steigerwald Gordon & Koch’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Steigerwald Gordon & Koch’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.5K	Hold	180	–	–	﹤0.01%	386
2026 Q1	$23K	Hold	180	–	–	﹤0.01%	402
2025 Q4	$21.9K	Hold	180	–	–	﹤0.01%	435
2025 Q3	$18K	Buy	+180	New	+$16.2K	﹤0.01%	445

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Steigerwald Gordon & Koch's XBI Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 180 shares worth $28.5K. The position accounts for ﹤0.01% of the portfolio, ranked #386.

Steigerwald Gordon & Koch first reported a position in XBI in Q3 2025 and has held it in 4 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Steigerwald Gordon & Koch held 180 shares of State Street SPDR S&P Biotech ETF worth $28.5K as of Q2 2026.
Steigerwald Gordon & Koch left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #386 holding.
Steigerwald Gordon & Koch first reported a position in State Street SPDR S&P Biotech ETF in Q3 2025 and has held it in 4 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.